Clinical Trial Update: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 trial evaluating Triapine as first- or second-line therapy for locally advanced or metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinar Cell Carcinoma of the Pancreas
• Ductal Adenocarcinoma of the Pancreas
• Pancreatic Cancer

Drugs mentioned

• Triapine (Triapine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas | Phase 2 | Status: COMPLETED